Canadian HIV Vaccine Initiative achievements report . : HP40-177/2017E-PDF

"The Canadian HIV Vaccine Initiative (CHVI), which concludes in March 2017, has been a unique collaboration between the Government of Canada (GoC) (the Public Health Agency of Canada (PHAC); Health Canada (HC); the Canadian Institutes of Health Research (CIHR); Innovation, Science and Economic Development (ISED); the National Research Council (NRC); and Global Affairs Canada (GAC)) and the Bill & Melinda Gates Foundation (BMGF) to further strengthen global efforts to accelerate the development of a safe, effective, affordable and globally accessible HIV vaccine. An investment of $139M (GoC - $111M from existing resources; BMGF - $28M) was made to support CHVI activities since 2007, a small investment considering that, in 2009, the total costs of HIV in Canada (loss of quality of life, health care costs, and productivity loss) was estimated at just over $4 billion. Overall, CHVI activities served to advance global research and development (R&D) on HIV vaccine research and other HIV-related research, and to increase the visibility of Canadian HIV vaccine research, both domestically and internationally … "--Executive summary, p. 1.

Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.833924&sl=1

• Format MARC XML
• Format MARC HTML

Demander des formats alternatifs